
GC38736
AS2863619
Also known as 4-[1-(2-methyl-3H-benzimidazol-5-yl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride
AS2863619 is an orally administered small molecule inhibitor of cyclin-dependent kinase (CDK) 8 and 19 with IC50 of 0·6099nM and 4·277nM, respectively
ChemicalCAS2241300-51-4MW405.24FormulaC16H14Cl2N8O
- CAS number
- 2241300-51-4
- Molecular weight
- 405.24
- Formula
- C16H14Cl2N8O
- Solubility
- DMSO: 250 mg/mL (616·92 mM)
- InChIKey
- LHUAALWRORLTCJ-UHFFFAOYSA-N
- Catalogue number
- GC38736
- Brand
- GLPBIO
Computed properties PubChem CID 139600293 · TPSA 124 Ų · H-bond donors 4 · H-bond acceptors 7
- TPSA
- 124 Ų
- H-bond donors
- 4
- H-bond acceptors
- 7
- Rotatable bonds
- 2
- Heavy atoms
- 27
SMILES CC1=NC2=C(N1)C=C(C=C2)N3C4=C(C=NC=C4)N=C3C5=NON=C5N.Cl.Cl
Computed descriptors from PubChem (CID 139600293), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il